<i>DPYD</i> and <i>TYMS</i> polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients-Reference-Cited by-同舟云学术

DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients

Published:2022-09-22 Issue: Volume: Page:1-10
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Khalij Yassine¹²,Belaid Imtinen³,Chouchane Sana¹²,Amor Dorra¹²,Omezzine Asma¹²,Ben rejeb Nabila¹²,ben Ahmed Slim³,Bouslama Ali¹

Affiliation:

1. Biochemistry Department, LR12SP11, Sahloul University Hospital, Sousse, Tunisia

2. University of Monastir Faculty of Pharmacy of Monastir, Monastir, Tunisia

3. Carcinology Department, Farhat Hached University Hospital, Sousse, Tunisia

Funder

Tunisian Ministry of Higher Education, Scientific Research and Technology, and the Ministry of Health

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2022.2125736

Reference51 articles.

1. Ferlay J, Soerjomataram I, Ervik M, et al. Lyon, France: international agency for research on cancer; 2013. Cancer Incidence and Mortality Worldwide: IARC Cancer Base. 2012;(11)

2. Systemic Therapy for Colorectal Cancer

3. Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil

4. DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy;International Journal of Molecular Sciences;2024-08-04

2. DPYD genetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: a systematic review;British Journal of Cancer;2024-06-17

3. Total neoadjuvant therapy in rectal cancer: the evidence and expectations;Critical Reviews in Oncology/Hematology;2023-12

4. Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the explanatory factors?;British Journal of Clinical Pharmacology;2023-03-30